179 related articles for article (PubMed ID: 28336525)
1. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia.
Leal-Lasarte MM; Franco JM; Labrador-Garrido A; Pozo D; Roodveldt C
FASEB J; 2017 Jul; 31(7):2797-2816. PubMed ID: 28336525
[TBL] [Abstract][Full Text] [Related]
2. MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS.
Pérez-Cabello JA; Silvera-Carrasco L; Franco JM; Capilla-González V; Armaos A; Gómez-Lima M; García-García R; Yap XW; Leal-Lasarte M; Lall D; Baloh RH; Martínez S; Miyata Y; Tartaglia GG; Sawarkar R; García-Domínguez M; Pozo D; Roodveldt C
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2302143120. PubMed ID: 37399380
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 activates microglia through NF-κB and NLRP3 inflammasome.
Zhao W; Beers DR; Bell S; Wang J; Wen S; Baloh RH; Appel SH
Exp Neurol; 2015 Nov; 273():24-35. PubMed ID: 26222336
[TBL] [Abstract][Full Text] [Related]
4. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
[TBL] [Abstract][Full Text] [Related]
5. Inflammation Induces TDP-43 Mislocalization and Aggregation.
Correia AS; Patel P; Dutta K; Julien JP
PLoS One; 2015; 10(10):e0140248. PubMed ID: 26444430
[TBL] [Abstract][Full Text] [Related]
6. NLRP3 Inflammasome Is Expressed and Functional in Mouse Brain Microglia but Not in Astrocytes.
Gustin A; Kirchmeyer M; Koncina E; Felten P; Losciuto S; Heurtaux T; Tardivel A; Heuschling P; Dostert C
PLoS One; 2015; 10(6):e0130624. PubMed ID: 26091541
[TBL] [Abstract][Full Text] [Related]
7. Induction of COX-2-PGE2 synthesis by activation of the MAPK/ERK pathway contributes to neuronal death triggered by TDP-43-depleted microglia.
Xia Q; Hu Q; Wang H; Yang H; Gao F; Ren H; Chen D; Fu C; Zheng L; Zhen X; Ying Z; Wang G
Cell Death Dis; 2015 Mar; 6(3):e1702. PubMed ID: 25811799
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis.
Kwong LK; Uryu K; Trojanowski JQ; Lee VM
Neurosignals; 2008; 16(1):41-51. PubMed ID: 18097159
[TBL] [Abstract][Full Text] [Related]
9. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
[TBL] [Abstract][Full Text] [Related]
10. [The molecular mechanisms of intracellular TDP-43 aggregates].
Nonaka T; Arai T; Hasegawa M
Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
[TBL] [Abstract][Full Text] [Related]
11. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Cai M; Lee KW; Choi SM; Yang EJ
Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
[TBL] [Abstract][Full Text] [Related]
12. Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function.
Li W; Reeb AN; Lin B; Subramanian P; Fey EE; Knoverek CR; French RL; Bigio EH; Ayala YM
J Biol Chem; 2017 Mar; 292(12):5089-5100. PubMed ID: 28167528
[TBL] [Abstract][Full Text] [Related]
13. Cell stress induces TDP-43 pathological changes associated with ERK1/2 dysfunction: implications in ALS.
Ayala V; Granado-Serrano AB; Cacabelos D; Naudí A; Ilieva EV; Boada J; Caraballo-Miralles V; Lladó J; Ferrer I; Pamplona R; Portero-Otin M
Acta Neuropathol; 2011 Sep; 122(3):259-70. PubMed ID: 21706176
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.
Chang CF; Lee YC; Lee KH; Lin HC; Chen CL; Shen CJ; Huang CC
J Biomed Sci; 2016 Oct; 23(1):72. PubMed ID: 27769241
[TBL] [Abstract][Full Text] [Related]
15. Enhancing survival motor neuron expression extends lifespan and attenuates neurodegeneration in mutant TDP-43 mice.
Perera ND; Sheean RK; Crouch PJ; White AR; Horne MK; Turner BJ
Hum Mol Genet; 2016 Sep; 25(18):4080-4093. PubMed ID: 27466204
[TBL] [Abstract][Full Text] [Related]
16. TAR DNA-binding protein 43 in neurodegenerative disease.
Chen-Plotkin AS; Lee VM; Trojanowski JQ
Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
[TBL] [Abstract][Full Text] [Related]
17. [Neurodegenerative disorders and TDP-43].
Nonaka T; Inukai Y; Arai T; Hasegawa M
Brain Nerve; 2009 Feb; 61(2):161-6. PubMed ID: 19235466
[TBL] [Abstract][Full Text] [Related]
18. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
[TBL] [Abstract][Full Text] [Related]
19. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
20. How do the RNA-binding proteins TDP-43 and FUS relate to amyotrophic lateral sclerosis and frontotemporal degeneration, and to each other?
Baloh RH
Curr Opin Neurol; 2012 Dec; 25(6):701-7. PubMed ID: 23041957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
